Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas

Oral Oncology ◽  
2011 ◽  
Vol 47 (8) ◽  
pp. 702-708 ◽  
Author(s):  
Gordana Supic ◽  
Ruzica Kozomara ◽  
Nebojsa Jovic ◽  
Katarina Zeljic ◽  
Zvonko Magic
Oral Oncology ◽  
2016 ◽  
Vol 52 ◽  
pp. 75-84 ◽  
Author(s):  
Manuel Weber ◽  
Christos Iliopoulos ◽  
Patrick Moebius ◽  
Maike Büttner-Herold ◽  
Kerstin Amann ◽  
...  

Author(s):  
G. Baretton ◽  
Xun Li ◽  
C. Stoll ◽  
E. Fischer-Brandies ◽  
M. Schmidt ◽  
...  

2020 ◽  
Author(s):  
Huijie Yu ◽  
Tianhua Li ◽  
Xuemei Mao

Abstract Background To investigate the expression of transcription factor Dickkopf-1 (DKK1) in oral squamous cell carcinomas (OSCC) by bioinformatics analysis and to clarify the connection between expression of DKK1 and clinicopathological features of OSCC, so as to elucidate the early diagnosis and prognostic significance of OSCC by DKK1. Methods This study used the GEPIA database in conjunction with the TCGA database to analyze the expression level of DKK1 in OSCC tissues and then verify it by QRTPCR and Western-blot analysis in vitro. The LinkedOmics database was used to describe the correlation between DKK1 expression and clinical pathological parameters of OSCC and its impact on prognosis. DKK1 was knocked down by RNA interference approach in SCC-4 and SCC-25 OSCC cell lines. In addition, the proliferation ability was assessed by MTT assay. Results DKK1 was highly expressed in OSCC and positively correlated with OSCC pathological grade and T stage. The results of TCGA showed that high DKK1 mRNA expression was associated with overall survival in OSCC. Besides, both DKK1 mRNA and protein expression was confirmed increased significantly in oral squamous cell carcinomas SCC-25 and SCC-4. Furthermore, MTT analysis investigated that knockdown of DKK1 caused reduced proliferation ability of OSCC cells. Conclusions The TCGA database analysis found that DKK1 is highly expressed in OSCC and is associated with multiple pathological indicators of OSCC, which will provide important theoretical guidance for subsequent oral squamous cell carcinoma research.


Oral Diseases ◽  
2016 ◽  
Vol 22 (4) ◽  
pp. 303-312 ◽  
Author(s):  
LS Monteiro ◽  
ML Delgado ◽  
S Ricardo ◽  
B do Amaral ◽  
F Salazar ◽  
...  

Oral Oncology ◽  
2003 ◽  
Vol 39 (6) ◽  
pp. 610-618 ◽  
Author(s):  
Ryozo Miyamoto ◽  
Narikazu Uzawa ◽  
Shunya Nagaoka ◽  
Yasushi Hirata ◽  
Teruo Amagasa

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Luís Silva Monteiro ◽  
Maria Leonor Delgado ◽  
Sara Ricardo ◽  
Fernanda Garcez ◽  
Barbas do Amaral ◽  
...  

The aim of our study was to explore the clinicopathological and prognostic significance of extracellular matrix metalloproteinase inducer (EMMPRIN) expression in oral squamous cell carcinomas (OSCC), and its relation with the proliferative tumor status of OSCC. We examined EMMPRIN and Ki-67 proteins expression by immunohistochemistry in 74 cases with OSCC. Statistical analysis was conducted to examine their clinicopathological and prognostic significance in OSCC. EMMPRIN membrane expression was observed in all cases, with both membrane and cytoplasmic tumor expression in 61 cases (82.4%). EMMPRIN overexpression was observed in 56 cases (75.7%). Moderately or poorly differentiated tumors showed EMMPRIN overexpression more frequently than well-differentiated tumors(P=0.002). Overexpression of EMMPRIN was correlated with high Ki-67 expression(P=0.004). In the multivariate analysis, EMMPRIN overexpression reveals an adverse independent prognostic value for cancer-specific survival (CSS)(P=0.034). Our results reveal that EMMPRIN protein is overexpressed in more than two-thirds of OSCC cases, especially in high proliferative and less differentiated tumors. The independent value of EMMPRIN overexpression in CSS suggests that this protein could be used as an important biological prognostic marker for patients with OSCC. Moreover, the high expression of EMMPRIN makes it a possible therapeutic target in OSCC patients.


2010 ◽  
Vol 44 (4) ◽  
pp. 360 ◽  
Author(s):  
Sook Hee Hong ◽  
Sang Young Roh ◽  
Yoon Ho Ko ◽  
Hye Sung Won ◽  
Myung Ah Lee ◽  
...  

2005 ◽  
Vol 1 (1) ◽  
pp. 92
Author(s):  
M. El Maaytah ◽  
N. Kalavrezos ◽  
D.R. Moles ◽  
A.W. Barrett ◽  
G. Thomas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document